Andrea Charles | 08/18/2011
Ottavio Arancio, Professor, Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Columbia University, speaks to Andrea Charles from Pharma IQ, about the goals of his current research, how the landscape for Alzheimer's disease drug discovery has changed in recent years and how novel PDE5 Inhibitors can be used as a therapeutic tool against Alzheimer's disease. Arancio also shares his thoughts on the future of memory research in drug discov...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More